AKT1 and pancreatic neoplasm: Pancreatic cancer cell lines highly resistant to chemotherapy are also resistant to all the tested inhibitors of EGFR, AKT, and PI3K due to compensatory pathways associated with anti-apoptosis [118,119], which may partly explain the failure of combining chemotherapy and targeted therapy.